Equities

Laboratorio Reig Jofre SA

Laboratorio Reig Jofre SA

Actions
  • Price (EUR)2.64
  • Today's Change0.02 / 0.76%
  • Shares traded200.00
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Sep 19 2024 18:31 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of EUR
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments6.496.906.04
Total Receivables, Net625550
Total Inventory624848
Prepaid expenses----0.26
Other current assets, total2.342.304.42
Total current assets133112109
Property, plant & equipment, net929392
Goodwill, net282930
Intangibles, net637178
Long term investments6.395.152.36
Note receivable - long term------
Other long term assets------
Total assets331321325
LIABILITIES
Accounts payable413635
Accrued expenses7.417.146.31
Notes payable/short-term debt000
Current portion long-term debt/capital leases302418
Other current liabilities, total118.5315
Total current liabilities907675
Total long term debt233749
Total debt536167
Deferred income tax2.632.803.05
Minority interest(0.1)(0.08)(0.08)
Other liabilities, total10119.44
Total liabilities126127136
SHAREHOLDERS EQUITY
Common stock403939
Additional paid-in capital191919
Retained earnings (accumulated deficit)150142134
Treasury stock - common(2.83)(2.82)(2.4)
Unrealized gain (loss)------
Other equity, total(1.95)(2.31)(0.63)
Total equity204195189
Total liabilities & shareholders' equity331321325
Total common shares outstanding808080
Treasury shares - common primary issue0.850.850.72
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.